Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1,3-dimethyl-5-aminoadamantane
2. 1-amino-3,5-dimethyladamantane
3. Axura
4. D 145
5. D-145
6. D145
7. Ebixa
8. Memantin
9. Memantine
10. Namenda
1. 41100-52-1
2. Memantine Hcl
3. Namenda
4. 3,5-dimethyl-1-adamantanamine Hydrochloride
5. 3,5-dimethyladamantan-1-amine Hydrochloride
6. Akatinol
7. Axura
8. Namenda Xr
9. Memary
10. Ebixa
11. Memantine Mylan
12. 1-amino-3,5-dimethyladamantane Hydrochloride
13. Memantine Merz
14. Memantine.hcl
15. Memantine Accord
16. Memantine Lek
17. Memantine (hydrochloride)
18. Acrescent
19. Balaxur
20. Auxura
21. Unii-jy0wd0ua60
22. 3,5-dimethyladamantan-1-amine;hydrochloride
23. Jy0wd0ua60
24. Mfcd00214336
25. Memantine Ratiopharm
26. Memantine Hydrochloride [usan]
27. Chebi:64323
28. Sun-y7017
29. Nsc-102290
30. 3,5-dimethyladamantan-1-aminium Chloride
31. D-145
32. Mls001332605
33. 3,5-dimethyl-1-aminoadamantane Hydrochloride
34. (3,5-dimethyl-1-adamantyl)amine Hydrochloride
35. 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine Hydrochloride
36. Fp-01
37. 1,3-dimethyl-5-adamantanamine Hcl
38. 3,5-dimethyltricyclo[3.3.1.13,7]decan-1-amine Hydrochloride
39. 41100-52-1 (hcl)
40. Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-, Hydrochloride
41. D 145
42. Mantine
43. Ebixza
44. 3,5-dimethyl-tricyclo[3.3.1.13,7]decan-1-amine Hydrochloride
45. 3,5-dimethyltricyclo(3.3.1.13,7)decan-1-amine Hydrochloride
46. 3,5-dimethyltricyclo(3.3.1.1(sup 3,7))decan-1-amine Hydrochloride
47. Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, 3,5-dimethyl-, Hydrochloride
48. 3,5-dimethyl-1-adamantylamine
49. 3,5-dimethyl-1-aminoadamantane
50. Smr000875213
51. Sr-01000075458
52. Sun Y7017
53. Einecs 255-219-6
54. Namenda (tn)
55. Memary (tn)
56. Marixino
57. Nsc 102290
58. D-145 (hydrochloride)
59. Schembl3053
60. C12h21n.hcl
61. Chembl1699
62. Mls001332606
63. Spectrum1501121
64. Hy-b0365a
65. Dtxsid90961439
66. Memantine Hydrochloride (namenda)
67. N06dx01
68. Nmi-131
69. Hms1571c17
70. Hms1921h03
71. Pharmakon1600-01501121
72. Memantine Hydrochloride (jan/usp)
73. Memantine Hydrochloride [mi]
74. Tox21_500861
75. Ac-559
76. Ccg-39018
77. Memantine Hydrochloride [jan]
78. Mrz-2/145
79. Nsc102290
80. Nsc757843
81. S2043
82. Akos015889460
83. Bcp9000253
84. Lp00861
85. Memantine Hydrochloride [mart.]
86. Nc00680
87. Memantine Hydrochloride [usp-rs]
88. Memantine Hydrochloride [who-dd]
89. Ncgc00094186-01
90. Ncgc00094186-02
91. Ncgc00094186-03
92. Ncgc00261546-01
93. As-13331
94. Bm164662
95. Memantine Hydrochloride [ema Epar]
96. Sy057917
97. 3,5-dimethyladamantan-1-aminehydrochloride
98. Am20070534
99. D3608
100. Eu-0100861
101. Ft-0650723
102. M-145
103. Memantine Hydrochloride [orange Book]
104. Sw060653-4
105. 1-amino-3,5-dimethyl-adamantane Hydrochloride
106. 3,5-dimethyladamantan-1-amine Hy-drochloride
107. 3,5-dimethyladamantan-1-amine;hydrochloride.
108. D04905
109. M 9292
110. Memantine Hydrochloride [usp Monograph]
111. Namzaric Component Memantine Hydrochloride
112. Memantine Hydrochloride Component Of Namzaric
113. Sr-01000075458-1
114. Sr-01000075458-3
115. Sr-01000075458-8
116. Q27133218
117. Z1551429722
118. Tricyclo(3.3.1.1(3,7))decan-1-amine, 3,5-dimethyl-, Hydrochloride
119. Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-, Hydrochloride (1:1) (ca Index Name)
120. 1-amino-3,5-dimethyladamantane . Hcl 3,5-dimethyl-1-aminoadamantane . Hcl Memantine . Hydrochloride
Molecular Weight | 215.76 g/mol |
---|---|
Molecular Formula | C12H22ClN |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Exact Mass | 215.1440774 g/mol |
Monoisotopic Mass | 215.1440774 g/mol |
Topological Polar Surface Area | 26 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 240 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Memantine hydrochloride |
PubMed Health | Memantine (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 5mg; 10mg |
Market Status | Tentative Approval |
Company | Amneal Pharms; Alembic; Upsher Smith; Mylan Pharma; Unichem Pharms (usa); Apotex; Lupin Pharms; Aurobindo Pharma; Torrent Pharms; Macleods Pharms; Jubilant Life |
2 of 6 | |
---|---|
Drug Name | Namenda |
PubMed Health | Memantine (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2mg/ml; 5mg; 10mg |
Market Status | Prescription |
Company | Forest Labs |
3 of 6 | |
---|---|
Drug Name | Namenda xr |
Drug Label | NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21NHCl and the molecular wei... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 7mg; 14mg; 21mg; 28mg |
Market Status | Prescription |
Company | Forest Labs |
4 of 6 | |
---|---|
Drug Name | Memantine hydrochloride |
PubMed Health | Memantine (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 5mg; 10mg |
Market Status | Tentative Approval |
Company | Amneal Pharms; Alembic; Upsher Smith; Mylan Pharma; Unichem Pharms (usa); Apotex; Lupin Pharms; Aurobindo Pharma; Torrent Pharms; Macleods Pharms; Jubilant Life |
5 of 6 | |
---|---|
Drug Name | Namenda |
PubMed Health | Memantine (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2mg/ml; 5mg; 10mg |
Market Status | Prescription |
Company | Forest Labs |
6 of 6 | |
---|---|
Drug Name | Namenda xr |
Drug Label | NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21NHCl and the molecular wei... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 7mg; 14mg; 21mg; 28mg |
Market Status | Prescription |
Company | Forest Labs |
Treatment of patients with moderate to severe Alzheimer's disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimer's disease.
Treatment of patients with moderate to severe Alzheimers disease
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of Alzheimers disease
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Dopamine Agents
Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06D
N06DA52
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?